These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fat invasion in ten-core prostate needle biopsies: incidence, biopsy and clinical findings. Billis A Int Braz J Urol; 2004; 30(4):346-7. PubMed ID: 15679981 [No Abstract] [Full Text] [Related]
6. Intraprostatic fat in a prostatic needle biopsy: a case report and review of the literature. Joshi A; Shah V; Varma M Histopathology; 2009 Jun; 54(7):912-3. PubMed ID: 19469911 [No Abstract] [Full Text] [Related]
8. [CONSTITUTIONAL STUDIES ON TUMOR OF THE PROSTATE. I. ON THE MEASUREMENT OF CONSTITUTION]. OGAWA M Hinyokika Kiyo; 1964 Oct; 10():677-85. PubMed ID: 14224745 [No Abstract] [Full Text] [Related]
9. MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness. Iordanescu G; Brendler C; Crawford SE; Wyrwicz AM; Venkatasubramanian PN; Doll JA J Magn Reson Imaging; 2015 Sep; 42(3):651-7. PubMed ID: 25522916 [TBL] [Abstract][Full Text] [Related]
10. Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens. Hong H; Koch MO; Foster RS; Bihrle R; Gardner TA; Fyffe J; Ulbright TM; Eble JN; Cheng L Cancer; 2003 Apr; 97(7):1639-43. PubMed ID: 12655520 [TBL] [Abstract][Full Text] [Related]
11. Body size and prostate cancer. Harv Mens Health Watch; 1999 Mar; 3(8):7. PubMed ID: 10066315 [No Abstract] [Full Text] [Related]
13. Human Periprostatic Adipose Tissue: Secretome from Patients With Prostate Cancer or Benign Prostate Hyperplasia. Sacca PA; Mazza ON; Scorticati C; Vitagliano G; Casas G; Calvo JC Cancer Genomics Proteomics; 2019; 16(1):29-58. PubMed ID: 30587498 [TBL] [Abstract][Full Text] [Related]
14. Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer. Bhindi B; Trottier G; Elharram M; Fernandes KA; Lockwood G; Toi A; Hersey KM; Finelli A; Evans A; van der Kwast TH; Fleshner NE BJU Int; 2012 Oct; 110(7):980-6. PubMed ID: 22372862 [TBL] [Abstract][Full Text] [Related]
15. Body mass and prostatic cancer: a prospective study. Severson RK; Grove JS; Nomura AM; Stemmermann GN BMJ; 1988 Sep; 297(6650):713-5. PubMed ID: 3147735 [TBL] [Abstract][Full Text] [Related]
16. Role of CT in staging prostate tumors. Fusco A; La Vecchia G; Vincenzoni M; Breda M; Colavita N; Danza FM Rays; 1985; 10(1):13-8. PubMed ID: 3843629 [No Abstract] [Full Text] [Related]
17. Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts. Lo JC; Clark AK; Ascui N; Frydenberg M; Risbridger GP; Taylor RA; Watt MJ Oncotarget; 2016 Jul; 7(30):47650-47662. PubMed ID: 27351281 [TBL] [Abstract][Full Text] [Related]
18. Pathologic implications of prostatic anterior fat pad. Jeong J; Choi EY; Kang DI; Ercolani M; Lee DH; Kim WJ; Kim IY Urol Oncol; 2013 Jan; 31(1):63-7. PubMed ID: 21396837 [TBL] [Abstract][Full Text] [Related]
19. Invasion of fat justifies assignment of stage pT3a in prostatic adenocarcinoma. Sung MT; Eble JN; Cheng L Pathology; 2006 Aug; 38(4):309-11. PubMed ID: 16916718 [TBL] [Abstract][Full Text] [Related]
20. Body size and composition and prostate cancer risk. MacInnis RJ; English DR; Gertig DM; Hopper JL; Giles GG Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1417-21. PubMed ID: 14693731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]